We propose novel adult zebrafish EAE model for multiple sclerosis drugs screening. Disease induction in this model is by using myelin oligodendrocyte glycoprotein. The model has been validated using fingolimod hydrochloride (Gilenya). Further, detailed validation has been conducted with three known EAE modulators. It offers to be a quick simple protocol between in vitro and rodent studies.